Ocular Therapeutix: Axpaxli’s Dual Trial Strategy And Blockbuster PotentialBy mariocazombo76@gmail.com / March 6, 2025
Neutral On Metagenomi’s Promising Yet Highly Speculative Gene Editing Potential January 28, 2025 / IONS, MGX, Myriam Alvarez / By mariocazombo76@gmail.com
Time To Be Bullish On Sanofi Ahead Of Its Earnings January 29, 2025 / KYMR, Myriam Alvarez, SNY, SNYNF, VIGL / By mariocazombo76@gmail.com